has emerged in that a strain of rat, the fawn-hooded rat (FHR) which has a susceptibility to developing PH with has come through recent therapeutic advances which prolong and improve quality of life. From this interest, mild hypoxia has an inherited storage defect to serotonin. Dexfenfluramine, by inhibiting the serotonin recent observations from family studies indicate that a gene located on chromosome 2 is associated with PH.
Introduction

Familial PPH
Pulmonary hypertension (PH) is defined at cardiac Familial PPH is more common in females and catheterisation, by a resting elevated mean pulmonappears to conform to an autosomal dominant ary artery pressure (mPAP) of Ͼ25 mm Hg. This inheritance with reduced penetrance. 7, 8 Genetic should be in the absence of an elevated pulmonary anticipation is observed with successive generations artery wedge pressure. There is a characteristic presenting with the disease at earlier ages. endovascular occlusion of the smallest pulmonary Recently the gene for familial PPH has been localarteries, caused by proliferation of cells and matrix ised to chromosome 2q31-32. 9 Following a genometogether with thrombosis and vasospasm. Increased wide search using a set of highly polymorphic short pulmonary vascular resistance can lead to death tandem repeat (STR) markers in 19 affected individthrough right ventricular failure.
uals from six families, initial evidence of linkage The diagnosis of PH has become relevant now that was obtained with two chromosome 2q markers. A treatment such as lung transplantation 1 and intrasubsequent genotyping of all the family members for venous prostacyclin 2 have proved effective in pro-19 additional markers spanning ෂ40 centiMorgans longing and improving quality of life. Also advances (cM) on the long arm of chromosome-2 yielded a in technology, in particular the non-invasive two-point LOD score of 6.97 O = 0 with marker measurement of systolic pulmonary artery pressure D2S389. Multipoint linkage analysis gave a LOD with M-mode echodoppler, have allowed screening score of 7.86 with marker D2S311. Haplotype analyfor the disease in mildly symptomatic patients.
sis established a minimum candidate interval of The most common forms of the disorder are those ෂ25 cM. A number of known candidate genes fall which are secondary to cardiac disease, both conwithin this interval including tissue factor pathway genital and acquired, and hypoxia from lung disease inhibitor. 10 Other potential candidates will be or from impaired ventilatory control. Systemic disidentified using the known human expressed eases such as sarcoidosis, systemic sclerosis and syssequence tags, 100 of which fall in the interval. Use temic lupus erythematosis are all associated with of more PPH families will also allow further narsevere PH. Finally, portal hypertension can also rowing of the critical interval and significantly limit cause PH.
the remaining candidate genes. Primary PH (PPH) is a term coined by Dresdale and colleagues 3 to cover those patients where PH
Environmental factors in PPH
remains unexplained after investigation for secondary forms. He also described first the familial form A number of exogenous factors have been identified of PPH. 4 This form is indistinguishable from PPH in in association with PPH. These include the use of terms of physiology or pathology 5 and occurs in cocaine 11 or oral contraceptives, 12 and HIV infecabout 6% of cases. 6 tion. 13 In the 1960s in Switzerland, Germany and Austria there was an epidemic of PPH associated with the anorectic agent aminorex fumarate. 14 In the early 1990s a French group reported a cluster of patients who have taken the anorectic dexfenfluramine who developed PPH. 15 Resulting from this
Correspondence: Dr A-M Gonzalez observation, an international prospective case-conrecent example has been seen in the Han people who invaded Tibet. Unlike native Tibetans they trol study was undertaken in four countries; France, Belgium, UK and the Netherlands. 16 develop PH more commonly. 26 Also the infants have a high incidence of infantile PH and polycythaeThere were 220 cardiothoracic centres which contributed to the study. A total of 95 index cases were mia. 27 A genetic sensitivity to hypoxia is a likely explanation. accepted, all had been vetted by an independent reviewer to exclude secondary causes of PH. For each two or three case controls, age and gender
The fawn hooded rat (FHR) matched were recruited from the patients' own general practitioner. Questionnaires were administered
The FHR offers a model for the susceptibility to PH with mild hypoxia as in man. Their value is further by professional but un-informed workers in each country.
enhanced by the recent description of an extensive genetic map with 130 markers. The FHR of interest The principle finding was an increased risk of PPH in those people with a history of taking anorechas a platelet pool storage disorder encoded by a single gene which maps to a region of chromosome-1 tic agents. Thirty cases (31.6%) of index cases had taken these agents compared with 26 (7.3%) of the containing the red-eye dilution gene (r). This is one of three recessive coat colour markers for which the controls, odds ratio of 7.1 (95% CI of 3.7 to 13.9). The odds ratio rose sharply in those who had taken strain is homozygous. This pool storage defect is part of a widespread storage disorder which of interthe drug for a longer period than 3 months, rising to 23.1. An incidence study gave an annual value of est also includes 5-HT (and other biogenic amines). Parallels with the effect of dexfen treatment have 1 per 500 000 of the population for PPH.
A number of mechanisms to account for these been drawn, where platelet 5-HT levels are also reduced and circulating levels are thought to be findings have been proposed. In common with aminorex, dexfenfluramine has a phenylethylamine higher than normal. Genetic studies of the FHR have indicated linkage structure. Whilst it can be demonstrated that pulmonary vasoconstriction can be produced by between r and the genes responsible for amine storage, systemic hypertension and renal impairment dexfen, 17 possibly through an action on a calcium dependent potassium channel on the smooth muscle which can develop in the strain. The Rf-1 and Rf-2 genes are responsible for about half of the genetic cells, 18 this is seen at concentrations in excess of those seen during treatment with the agent.
variation in key indices of renal failure. The Bpfh-1 is responsible for 26% of the variation on systemic It also can inhibit uptake of 5-HT by endothelial and neural cells together with platelets, through hypertension; all are localised to the chromosome 1 close to r.
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inhibition of the serotonin transporter. 19 This may lead to elevated circulating levels of 5-HT, itself a Unlike other strains of rat, PH occurs in the FHR during perinatal exposure to mild hypoxia. This PH vasoconstrictor. 20 However, we have shown that chronic treatment with dexfen actually reduces the shows the characteristic remodelling of pulmonary hypertension and increased expression of the prepulmonary vascular responses to 5-HT. This indicates a possible influence of dexfen on the pro ET-1 mRNA.
29,30
Restoration of normoxia inhibits the development of PH in the FHR. expression of 5-HT receptors. 21 Finally dexfen can alter the balance of the production of the vasoactive Perinatal hypoxia, as with other adverse in utero conditions which reduce birth weight are known to thromboxane and prostacyclin. As yet no clear explanation is available for the relationship between enhance the prevalence and mortality from coronary artery disease. 31, 32 It has been argued that it might dexfen and PPH. also cause adult PH. 33 Whilst in Wistar rats we have not been able to show evidence of PH in adult rats
Hypoxia and PH
who had been exposed to perinatal hypoxia, marked changes were observed. We found increased A more common environmental factor leading to PH is hypoxia. About 10% of patients with severe airexpression of mRNA for pre-pro ET-1 and reduced expression of NOS III mRNA, together with altered ways obstruction from chronic obstructive bronchitis develop secondary PH. The worse the hypoxia compliance of the pulmonary vasculature. 34 It suggests that development of the pulmonary circulation the greater the risk. The same occlusive vascular lesions are seen in the condition as in PPH, howcan be altered by perinatal hypoxia and this effect persists until adult life. In the FHR we suspect that ever, there is evidence that reversal occurs with long-term oxygen therapy (LTOT). 22 Not only is surthis adaptation is exaggerated. vival improved by LTOT but the elevated pulmonary vascular resistance can be reduced.
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Conclusion
Not only is lung disease a cause of hypoxic PH but the same also appears true of congenital heart
Here we have described how environment and inheritance appear to interact to contribute to the disease. A study of LTOT in Eisenmengers Syndrome shows that again survival is improved. 24 It development of PH in man and animal models. Location of the genes for familial PPH and susceptihas been recognised that susceptibility to hypoxia occurs in a number of animals, for instance in cattle, bility to hypoxia seem likely to be identified in the near future. An interesting link between the anorecsheep and the Yak, strains appear sensitive to hypoxia in developing severe PH. 25 tic agents which disturb biogenic amine metabolism and susceptibility to hypoxia in the FHR potentially The same may also be true in man. The most 
